Chemical inhibitors of RPL14 include a range of compounds that target the ribosomal machinery central to protein synthesis, where RPL14 plays a critical role. Anisomycin is one such inhibitor that binds to the 60S ribosomal subunit, impeding peptide bond formation and consequently stalling the ribosomal function that RPL14 is part of. Similarly, Cycloheximide is known to block the translocation step on ribosomes, freezing RPL14's role during mRNA translation. Ricin further compromises RPL14's functionality by inactivating the 60S subunit through depurination of rRNA, which disrupts the ribosome's interaction with elongation factors crucial for protein synthesis. Alpha-sarcin contributes to this suite of inhibitors by cleaving rRNA within the ribosomal active site, undermining the integrity of the ribosome and thus the functional contribution of RPL14.
Emetine and Harringtonine inhibit protein synthesis by different mechanisms, yet both impact RPL14's involvement in translation. Emetine binds to the 40S subunit and blocks the movement of the ribosome along mRNA, directly inhibiting RPL14's participation in translation. Harringtonine, on the other hand, prevents amino acid incorporation into elongating peptide chains, thus disrupting RPL14's role in ribosome assembly. Homoharringtonine and Pactamycin also inhibit the elongation step and the initiation of protein synthesis, respectively, which restricts RPL14's engagement with the ribosome during these critical stages. Puromycin causes premature chain termination by mimicking aminoacyl-tRNA, effectively inhibiting RPL14 by interrupting the elongation process it facilitates. Sparsomycin and Streptovitacin A interfere with peptide bond formation and the translocation process, respectively, undermining the role of RPL14 in these fundamental processes. Lastly, Tunicamycin disrupts proper protein folding by inhibiting N-linked glycosylation, impacting RPL14's integration into functional ribosomes and, therefore, its role in protein synthesis. Each of these chemicals impairs the ribosome's function, which is integral to the protein-producing role of RPL14, rendering it functionally inhibited.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin inhibits protein synthesis by binding to the 60S ribosomal subunit, preventing peptide bond formation, which is a crucial step in the elongation cycle. This would functionally inhibit RPL14 by stalling ribosome function. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide blocks the translocation step in protein synthesis on ribosomes, thereby inhibiting the function of RPL14 by freezing its role in the ribosome during mRNA translation. | ||||||
α-Sarcin | 86243-64-3 | sc-204427 | 1 mg | $462.00 | 6 | |
Alpha-sarcin cleaves a specific phosphodiester bond in the rRNA, inhibiting ribosome function and therefore inhibiting RPL14's role in protein synthesis by disrupting the integrity of the ribosomal active site. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine binds to the 40S ribosomal subunit, blocking the movement of the ribosome along mRNA, which would inhibit RPL14 by preventing it from participating in the translation process. | ||||||
Harringtonin | 26833-85-2 | sc-204771 sc-204771A sc-204771B sc-204771C sc-204771D | 5 mg 10 mg 25 mg 50 mg 100 mg | $250.00 $367.00 $548.00 $730.00 $980.00 | 30 | |
Harringtonine inhibits the initial stages of protein synthesis by preventing the incorporation of amino acid into elongating peptide chains, thereby inhibiting RPL14 by disrupting its role in ribosome assembly. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Homoharringtonine inhibits protein synthesis at the chain elongation step, which would inhibit RPL14 by preventing its normal function during the assembly of the ribosome and polypeptide formation. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination by acting as an analog of aminoacyl-tRNA, which would inhibit RPL14 by interrupting its role in the elongation and proper assembly of functional ribosomes. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which is crucial for the folding and stability of many proteins. By disrupting proper protein folding, it would inhibit RPL14's integration into functional ribosomes. | ||||||